Vikram Thermo India [VIKRAMTH] vs Aarti Drugs [AARTIDRUGS] Detailed Stock Comparison

Vikram Thermo India

BSE
Loading...

Aarti Drugs

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Vikram Thermo India wins in 11 metrics, Aarti Drugs wins in 9 metrics, with 0 ties. Vikram Thermo India appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricVikram Thermo IndiaAarti DrugsBetter
P/E Ratio (TTM)15.8423.66Vikram Thermo India
Price-to-Book Ratio4.303.26Aarti Drugs
Debt-to-Equity Ratio5.2744.92Vikram Thermo India
PEG Ratio-0.110.37Vikram Thermo India
EV/EBITDA11.9517.07Vikram Thermo India
Profit Margin (TTM)25.77%7.80%Vikram Thermo India
Operating Margin (TTM)37.09%10.11%Vikram Thermo India
EBITDA Margin (TTM)37.09%10.11%Vikram Thermo India
Return on Equity6.67%12.28%Aarti Drugs
Return on Assets (TTM)5.55%6.53%Aarti Drugs
Free Cash Flow (TTM)$-171.83M$674.22MAarti Drugs
Dividend Yield1.03%0.22%Vikram Thermo India
1-Year Return-3.14%-4.79%Vikram Thermo India
Price-to-Sales Ratio (TTM)4.221.84Aarti Drugs
Enterprise Value$5.29B$50.47BAarti Drugs
EV/Revenue Ratio4.282.08Aarti Drugs
Gross Profit Margin (TTM)66.18%36.77%Vikram Thermo India
Revenue per Share (TTM)$39$265Aarti Drugs
Earnings per Share (Diluted)$10.52$20.63Aarti Drugs
Beta (Stock Volatility)-0.320.12Vikram Thermo India
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Vikram Thermo India vs Aarti Drugs Stock Performance Analysis

Loading Price Chart...

Vikram Thermo India
Aarti Drugs
Vikram Thermo India Stock Overview | Aarti Drugs Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Vikram Thermo India-0.87%2.36%1.85%7.10%-7.19%-5.44%
Aarti Drugs0.73%4.61%0.24%1.59%41.06%7.93%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Vikram Thermo India-3.14%205.27%-16.57%140.57%551.48%307.27%
Aarti Drugs-4.79%-0.89%-50.06%219.30%2,690.01%2,872.19%

News Based Sentiment: Vikram Thermo India vs Aarti Drugs

Vikram Thermo India

News based Sentiment: MIXED

September presented a mixed bag for Vikram Thermo, with a notable profit turnaround offsetting a revenue decline. The AGM and subsequent management changes, coupled with shifts in shareholding, add complexity to the investment picture. While the company's financial health appears strong, the fluctuating share price and evolving leadership warrant careful monitoring.

View Vikram Thermo India News Sentiment Analysis

Aarti Drugs

News based Sentiment: POSITIVE

Aarti Drugs reported substantial profit growth in both Q1FY26 and FY2025, coupled with increased institutional interest from Mutual Funds. While shareholding changes and recent price volatility exist, the overall narrative points towards a strengthening investment case.

View Aarti Drugs News Sentiment Analysis

Performance & Financial Health Analysis: Vikram Thermo India vs Aarti Drugs

MetricVIKRAMTHAARTIDRUGS
Market Information
Market Cap i₹5.35B₹44.55B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i6,814201,942
90 Day Avg. Volume i11,424187,563
Last Close₹165.15₹491.60
52 Week Range₹126.85 - ₹216.45₹312.00 - ₹564.05
% from 52W High-23.70%-12.84%
All-Time High₹311.00 (Apr 25, 2022)₹1,026.95 (Oct 05, 2020)
% from All-Time High-46.90%-52.13%
Growth Metrics
Quarterly Revenue Growth-0.08%0.06%
Quarterly Earnings Growth-0.08%0.62%
Financial Health
Profit Margin (TTM) i0.26%0.08%
Operating Margin (TTM) i0.37%0.10%
Return on Equity (TTM) i0.07%0.12%
Debt to Equity (MRQ) i5.2744.92
Cash & Liquidity
Book Value per Share (MRQ)₹38.75₹149.84
Cash per Share (MRQ)₹0.17₹2.48
Operating Cash Flow (TTM) i₹325.14M₹2.83B
Levered Free Cash Flow (TTM) i₹80.99M₹1.68B
Dividends
Last 12-Month Dividend Yield i1.03%0.22%
Last 12-Month Dividend i₹1.75₹1.00

Valuation & Enterprise Metrics Analysis: Vikram Thermo India vs Aarti Drugs

MetricVIKRAMTHAARTIDRUGS
Price Ratios
P/E Ratio (TTM) i15.8423.66
Forward P/E iN/A15.02
PEG Ratio i-0.110.37
Price to Sales (TTM) i4.221.84
Price to Book (MRQ) i4.303.26
Market Capitalization
Market Capitalization i₹5.35B₹44.55B
Enterprise Value i₹5.29B₹50.47B
Enterprise Value Metrics
Enterprise to Revenue i4.282.08
Enterprise to EBITDA i11.9517.07
Risk & Other Metrics
Beta i-0.320.12
Book Value per Share (MRQ) i₹38.75₹149.84

Financial Statements Comparison: Vikram Thermo India vs Aarti Drugs

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)VIKRAMTHAARTIDRUGS
Revenue/Sales i₹286.05M₹5.91B
Cost of Goods Sold i₹96.75M₹3.73B
Gross Profit i₹189.30M₹2.17B
Research & Development iN/AN/A
Operating Income (EBIT) i₹106.08M₹593.60M
EBITDA i₹114.82M₹743.90M
Pre-Tax Income i₹106.57M₹511.10M
Income Tax i₹27.15M₹-28.60M
Net Income (Profit) i₹79.41M₹539.70M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)VIKRAMTHAARTIDRUGS
Cash & Equivalents i₹1.62M₹45.77M
Total Current Assets i₹627.63M₹13.38B
Total Current Liabilities i₹200.68M₹8.37B
Long-Term Debt i₹21.88M₹2.86B
Total Shareholders Equity i₹1.21B₹13.69B
Retained Earnings i₹806.21M₹12.40B
Property, Plant & Equipment i₹27.49M₹27.03M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)VIKRAMTHAARTIDRUGS
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricVIKRAMTHAARTIDRUGS
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i6,814201,942
Average Daily Volume (90 Day) i11,424187,563
Shares Outstanding i31.36M91.27M
Float Shares i9.25M39.04M
% Held by Insiders i0.68%0.60%
% Held by Institutions i0.00%0.11%

Dividend Analysis & Yield Comparison: Vikram Thermo India vs Aarti Drugs

MetricVIKRAMTHAARTIDRUGS
Last 12-Month Dividend i₹1.75₹1.00
Last 12-Month Dividend Yield i1.03%0.22%
3-Year Avg Annual Dividend i₹0.75₹1.00
3-Year Avg Dividend Yield i0.50%0.23%
3-Year Total Dividends i₹2.25₹3.00
Ex-Dividend DateSep 19, 2025Feb 04, 2025